Vertex Pharmaceuticals (VRTX) Revenue and Net Income History
Historical revenue, operating income and net income for Vertex Pharmaceuticals (VRTX) over the last 10 years. The current TTM revenue for Vertex Pharmaceuticals as of February 21, 2018 is $2.49B.
|Medical||Medical - Biomedical and Genetics||$40.087B||$2.489B|
|Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.|